Fingerprint
Dive into the research topics of 'Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
Angela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, Carmen Tur, Mar Tintoré, Alejandro Horga, Cristina Auger, Jordi Río, Carlos Nos, Mari C. Edo, María J. Arévalo, Joaquín Castilló, Alex Rovira, Xavier Montalban
Research output: Contribution to journal › Article › Research › peer-review
80
Citations
(Scopus)